πŸ‡ΊπŸ‡Έ FDA
Patent

US 7994132

Peptides for treatment of scleroderma

granted A61KA61K31/22A61K31/366

Quick answer

US patent 7994132 (Peptides for treatment of scleroderma) held by The Regents of the University of California expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/22, A61K31/366, A61K31/40, A61K31/405